Skip Navigation


NDT Advance Access originally published online on July 17, 2007
Nephrology Dialysis Transplantation 2007 22(10):3082-3083; doi:10.1093/ndt/gfm473
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/10/3082    most recent
gfm473v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Benjelloun, M.
Right arrow Articles by Ramdani, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benjelloun, M.
Right arrow Articles by Ramdani, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org



(Section Editor: G. H. Neild)

Marked facial enlargement in secondary hyperparathyroidism

Meryem Benjelloun, Faissal Tarrass, Laila Alaoui, Ghislaine Medkouri, Khadija Hachim, Mohamed Benghanem Gharbi and Benyounes Ramdani

Department of Nephrology & Dialysis, Ibn Rochd University Hospital Center, 20100 Casablanca, Morocco

Correspondence to: Dr Faissal Tarrass, Salama 3, Gr 6, B, N° 21, 20450 Casablanca, Morocco. Email: faissal76{at}hotmail.com

Keywords: Brown tumour; ERSD; secondary hyper parathyroidism; maxillary bone

Brown tumours in patients with ESRD represent an extreme form of osteodystrophy. They occur most often in the long bones, ribs and pelvis, but can be found in any bone [1,2]. Clinically significant lesions in the jaws are rare [2]. We report a haemodialysis (HD) patient with a rapidly growing maxillary mass diagnosed as a brown tumour. The case is noteworthy because of the patient's young age, location, large size of the lesion and unusual course of the disease.

A 17-year-old female had been on a regular haemodialysis programme three times a week because of chronic glomerulonephritis since February 2000. She was non-compliant to dietary prescriptions and did not take phosphate binders as prescribed. Therefore, she soon developed hyperphosphoraemia (up to 7.4 mg/dl) and hypocalcaemia (7.5 mg/dl). At the start of HD, PTH levels were normal. Overt secondary hyperparathyroidism (HPT) became evident by March 2004, intact PTH increased up to 1483 pg/ml and circulating markers of bone metabolism were suggestive of a high-turnover bone disease. No signs of aluminium intoxication were found. Other clinical problems included pruritus and bone pain. Parathyroidectomy was proposed but was refused by the patient. In September 2004 a hard maxillary swelling appeared. The maxillary tumour was not painful, but its progressive growth caused a marked deformity of the face (Figure 1). A lateral radiograph of the face showed generalized fibrous dysplasia of maxilla and mandible (Figure 2). CT scans revealed that the tumour was almost homogeneous and that it was invading and destroying the maxilla. A surgical biopsy of the maxillary lesion was taken and the histopathological diagnosis was brown tumour. In the context of the patient's severe HPT, and the rapid growth of the maxillary lesion, a surgical parathyroidectomy was performed in October 2004. After surgery, profound hypocalcaemia and hypophosphataemia developed, with nearly undetectable intact PTH. This ‘hungry bone’ condition required treatment with oral alphacalcidol (2 µg daily) and elemental Ca supplementation (12 g daily). After parathyroidectomy, the bone tumour gradually diminished, diffuse bone pain abated and pruritus became less. Ca x P declined to normal values within one year and PTH levels remained persistently low. Repeated CT examination showed a progressive decrease in the size of the tumour and refilling of the lesions by calcific material.


Figure 1
View larger version (98K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 1. Lesion causing facial aesthetic deformity. (A) anterior-posterior and (B) oblique views.

 

Figure 2
View larger version (109K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 2. Lateral radiograph of the face showing generalized fibrous dysplasia of maxilla and mandible.

 
Brown tumours are probably slightly more frequent in primary than in secondary HPT. Nevertheless, the rate of these lesions in patients with secondary HPT due to chronic renal failure is highly variable, ranging from 1.5% up to more than 13% [1].

Rapid tumour disappearance or regression is well-documented, after parathyroidectomy, but in certain anatomical sites, decompression of the brown tumour is urgently needed because these lesions expand and can cause local destruction [1]. This is particularly true for maxillary lesions, which may lead to serious deformities of the face and even to a lethal outcome [3]. In our case, the surgical excision of the maxillary mass was not established due to the important size of the tumour.

Conflict of interest statement. None declared.

Notes

See http://www.oxfordjournals.org/our_journals/ndtplus/

References

  1. Tarrass F, Ayad A, Benjelloun M, et al. Cauda equina compression revealing brown tumor of the spine in a long-term hemodialysis patient. Joint Bone Spine (2006) 73:748–750.[CrossRef][Web of Science][Medline]
  2. Krause I, Eisenstein B, Davidovits M, Cleper R, Tobar A, Calderon S. Maxillomandibular brown tumor: a rare complication of chronic renal failure. Pediatr Nephrol (2000) 14:499–501.[CrossRef][Web of Science][Medline]
  3. Dantas M, Costa RS, Jorgetti V, et al. Facial leontiasis ossea: a rare presentation of hyperparathyroidism secondary to chronic renal insufficiency. Nephron (1991) 58:475–478.[Web of Science][Medline]
Received for publication: 22. 5.07
Accepted in revised form: 21. 6.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/10/3082    most recent
gfm473v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Benjelloun, M.
Right arrow Articles by Ramdani, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benjelloun, M.
Right arrow Articles by Ramdani, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?